BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu S, Zhang S, Ju R, Xiao Y, Wang X, Song X, Gu L, Cheng L, Li X, Chen G. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma. European Journal of Pharmaceutical Sciences 2017;106:185-97. [DOI: 10.1016/j.ejps.2017.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Lv Z, Cao Y, Xue D, Zhang H, Zhou S, Yin N, Li W, Jin L, Wang Y, Zhang H. A multiphoton transition activated iron based metal organic framework for synergistic therapy of photodynamic therapy/chemodynamic therapy/chemotherapy for orthotopic gliomas. J Mater Chem B 2023;11:1100-7. [PMID: 36629834 DOI: 10.1039/d2tb02273g] [Reference Citation Analysis]
2 Iqubal MK, Kaur H, Md S, Alhakamy NA, Iqubal A, Ali J, Baboota S. A technical note on emerging combination approach involved in the onconanotherapeutics. Drug Deliv 2022;29:3197-212. [PMID: 36226570 DOI: 10.1080/10717544.2022.2132018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zha S, Wong KL, All AH. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Adv Healthc Mater 2022;11:e2102610. [PMID: 35166052 DOI: 10.1002/adhm.202102610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Lv Z, Jin L, Cao Y, Zhang H, Xue D, Yin N, Zhang T, Wang Y, Liu J, Liu X, Zhang H. A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-II fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma. Light Sci Appl 2022;11:116. [PMID: 35487896 DOI: 10.1038/s41377-022-00794-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
5 Mojarad-Jabali S, Farshbaf M, Hemmati S, Sarfraz M, Motasadizadeh H, Shahbazi Mojarrad J, Atyabi F, Zakeri-Milani P, Valizadeh H. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Int J Pharm 2021;613:121395. [PMID: 34933080 DOI: 10.1016/j.ijpharm.2021.121395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
6 Mojarad-Jabali S, Farshbaf M, Walker PR, Hemmati S, Fatahi Y, Zakeri-Milani P, Sarfraz M, Valizadeh H. An update on actively targeted liposomes in advanced drug delivery to glioma. Int J Pharm 2021;602:120645. [PMID: 33915182 DOI: 10.1016/j.ijpharm.2021.120645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
7 Annu, Sartaj A, Aggarwal N, Qamar Z, Tabassum H, Narang JK, Baboota S, Ali J. Liposomal nanocarriers for delivery of combination drugs. Nanocarriers for the Delivery of Combination Drugs 2021. [DOI: 10.1016/b978-0-12-820779-6.00005-0] [Reference Citation Analysis]
8 Liu Y, Xie X, Chen H, Hou X, He Y, Shen J, Shi J, Feng N. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery. Nanomedicine: Nanotechnology, Biology and Medicine 2020;29:102237. [DOI: 10.1016/j.nano.2020.102237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li J, Tan T, Zhao L, Liu M, You Y, Zeng Y, Chen D, Xie T, Zhang L, Fu C, Zeng Z. Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review. ACS Appl Bio Mater 2020;3:5500-28. [PMID: 35021787 DOI: 10.1021/acsabm.0c00705] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
10 Alavi M, Varma RS. Overview of novel strategies for the delivery of anthracyclines to cancer cells by liposomal and polymeric nanoformulations. Int J Biol Macromol 2020;164:2197-203. [PMID: 32763404 DOI: 10.1016/j.ijbiomac.2020.07.274] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
11 Agarwal S, Maekawa T. Nano delivery of natural substances as prospective autophagy modulators in glioblastoma. Nanomedicine 2020;29:102270. [PMID: 32702467 DOI: 10.1016/j.nano.2020.102270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Niu J, Wang L, Yuan M, Zhang J, Chen H, Zhang Y. Dual-targeting nanocarrier based on glucose and folic acid functionalized pluronic P105 polymeric micelles for enhanced brain distribution. Journal of Drug Delivery Science and Technology 2020;57:101343. [DOI: 10.1016/j.jddst.2019.101343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang J, Li X, Huang L. Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Adv Drug Deliv Rev 2020;154-155:245-73. [PMID: 32473991 DOI: 10.1016/j.addr.2020.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
14 Peng Y, Bariwal J, Kumar V, Tan C, Mahato RI. Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment. Adv Therap 2020;3:1900136. [DOI: 10.1002/adtp.201900136] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
15 Kullberg M, Francian A, Arabi A, Olsson T, Mann K, Martinson HA. Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer. Pharm Front 2019;1:e190007. [PMID: 31886474 DOI: 10.20900/pf20190007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Liu JJ, Tang W, Fu M, Gong XQ, Kong L, Yao XM, Jing M, Cai FY, Li XT, Ju RJ. Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol 2019;47:1947-60. [PMID: 31079495 DOI: 10.1080/21691401.2019.1615932] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
17 Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. Int J Nanomedicine 2019;14:4071-90. [PMID: 31239668 DOI: 10.2147/IJN.S194304] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
18 Xiao Y, Cheng L, Xie HJ, Ju RJ, Wang X, Fu M, Liu JJ, Li XT. Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma. Artif Cells Nanomed Biotechnol 2018;46:S524-37. [PMID: 30299160 DOI: 10.1080/21691401.2018.1501377] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
19 Ju R, Mu L, Li X, Li C, Cheng Z, Lu W. Development of functional docetaxel nanomicelles for treatment of brain glioma. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:1180-90. [DOI: 10.1080/21691401.2018.1446971] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]